Acquiring Company
Pfizer
Acquired Company
Biohaven
New YorkNew HavenBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmapharmaceuticalsBiotechnologyHealth CareTherapeuticsDescription
Pfizer Inc. (NYSE: PFE) and Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven, the maker of NURTEC® ODT, an innovative dual-acting migraine therapy approved for both acute treatment and episodic prevention of migraine in adults.
Quick answer
Pfizer is acquiring Biohaven, announced May 10, 2022. Pfizer is based in New York, New York, United States.
- How much did Pfizer pay for Biohaven?
- The deal value was not disclosed.
- Where are Pfizer and Biohaven based?
- Pfizer is based in New York, New York, United States. Biohaven is based in New Haven, Connecticut, United States.
- Who are the decision-makers at Pfizer?
- Fundz holds 2 contacts at Pfizer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Pfizer Completes Acquisition Of Reviral (June 9, 2022)
- Bristol Myers Squibb To Acquire Turning Point Therapeutics, A Leading Precision Oncology Company (June 3, 2022)
- Halozyme Completes Antares Pharma Acquisition (May 24, 2022)
- Aprea Therapeutics Announces Acquisition Of Atrin Pharmaceuticals Inc. And Reports First Quarter 2022 Financial Results (May 16, 2022)
- Hikma Completes Acquisition Of Custopharm (April 21, 2022)
- Halozyme To Acquire Antares Pharma To Create A Specialty Product And Drug Delivery Leader (April 13, 2022)
Who to call at Pfizer, and when
When Pfizer changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Pfizer raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pfizer, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pfizer. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pfizer makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Biohaven?
Biohaven was acquired by Pfizer, based in New York. The deal was reported on May 10, 2022. Pfizer is publicly traded (PFE) and operates in Biotechnology.
When did Pfizer acquire Biohaven?
Pfizer's acquisition of Biohaven was reported on May 10, 2022. Pfizer Inc. (NYSE: PFE) and Biohaven Pharmaceutical Holding Company Ltd. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Biohaven do?
Biohaven is a commercial-stage biopharmaceutical company with a portfolio of innovative, best-in-class therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, including rare disorders. It is publicly traded (BHVN), operating in Biotechnology, and is based in New Haven.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.